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Releases of Aedes aegypti mosquitoes carrying Wolbachia toblock the transmission of dengue virus (DENV) are cur-rently being deployed as a novel dengue control strategy in
a number of countries, with very encouraging results1,2. In their
paper entitled “Variation in Wolbachia effects on Aedes mos-
quitoes as a determinant of invasiveness and vectorial capacity”,
King et al.3 used DENV infection and transmission modelling to
reinterpret experimental data from two previous studies4,5. The
authors claimed that wMel Wolbachia increase the mean sus-
ceptibility of Ae. aegypti to DENV, contradicting various other
studies6–12. Here, we raise concerns with the experimental
approaches used to generate one of the primary datasets on which
the modelling is based, and we discuss how these limitations
could make some of the original conclusions misleading.
King et al.3 base a large part of their modelling analysis on
experimental data reported in Souto-Maior et al.4, consisting of
intrathoracic challenges with DENV-1 of wMel-carrying and
tetracycline-cured (TET) Ae. aegypti, with virus quantified by
qRT-PCR in whole bodies. An equivalent proportion of dengue-
positive wMel-carrying mosquitoes compared to TET controls is
reported at an injection titre of 104 TCID50/ml, a slight increase
in positives in wMel-carrying mosquitoes at 105 and 106 TCID50/
ml, and a slight decrease at 107 and 108 TCID50/ml. Intrathoracic
inoculation can be a convenient first approximation of infectivity
since it is easier to perform than oral challenge; however it
bypasses the biologically crucial midgut infection barrier, a key
site of virus blocking by Wolbachia13. Thus, it represents a sub-
stantial deviation from the natural infection route, and its bio-
logical relevance is especially questionable given the binary
presence/absence of viral RNA used by King et al.3 as the measure
of susceptibility.
Furthermore, in Souto-Maior et al.4 a high proportion of the
mosquitoes assigned as DENV-infected, particularly those at low
virus titre challenges, are likely false positives. Examination of the
raw qPCR cycle threshold (Ct) values reveals a positive signal in 5
out of 35 negative control mosquitoes following mock challenge.
The mean of these Ct values is lower, indicating a stronger signal,
than many of the Ct values from mosquitoes counted as DENV-
infected (Fig. 1a). A strong signal in the negative control leads to
uncertainty over the specificity of the qPCR assay used and
suggests that many of the readings indicating DENV-positivity
from the 104, 105, 106, and 107 TCID50/ml inoculations could be
artefacts. The very low infection rates at the lower virus inocu-
lation titres are similar to the false positive rate of the negative
controls: 4% (0.4–13.7%), 8.8% (1.8–23.7%), and 18.4%
(8.4–30.9%), for 104, 105, and 106 TCID50/ml, respectively,
compared to 14.3% (4.8–30.3%) for negative controls, where all
percentage values in parentheses are exact binomial 95% CI.
Despite a low number of virus-positive mosquitoes at the lower
inoculation titres, with a total of 14 positive mosquitoes across
both the wMel and TET groups for the 104, 105, and 106 TCID50/
ml inoculations combined, resulting in low statistical power
(Fig. 1b), King et al.3 fit a dose-response model to the data and
conclude that “Wolbachia increase mean susceptibility [to infec-
tion] by a factor of 6.9”. Even if all DENV-positive PCR readings
are assumed to be valid, this increase in susceptibility is difficult
to reconcile with the data. The total proportion of DENV-positive
TET mosquitoes was 52 out of 117 or 44.4% (35.3–53.9%)
compared to 62 out of 143 or 43.3% (35.1–51.9) for wMel, a slight
decrease in infection rate that was not statistically significant: p=
0.96, Binomial test (Fig. 1c). There are also very low infection
rates and infection titres in the Souto-Maior et al.4 dataset even at
relatively high inoculation titres, e.g., an 8.3% infection rate in
TET mosquitoes following DENV-inoculation at 106 TCID50/ml.
This result is inconsistent with other studies: for example, 100%
infection was observed following DENV inoculation at 104 gen-
ome copies/ml11; 95% infection following DENV-inoculation at
105 TCID50/ml10; and 100% infection following DENV inocu-
lation at 6 × 105 PFU/ml14. Finally, there are issues with data
transfer, since King et al.3 present the wMel cohort as having a
higher proportion DENV infected at 104 TCID50/ml, whereas in
the Souto-Maior et al.4 dataset the proportions are equivalent.
The second dataset used by King et al.3 was from Ferguson
et al.5, comparing wMel-carrying and Wolbachia-negative Ae.
aegypti fed on viremic blood from dengue patients (serotypes
1–4). The study provides data on DENV infection rates and
titres in dissected abdomens by qRT-PCR, and a direct
assessment of the infectivity of mosquito saliva. Applying their
dose-response modelling to proportions of infected abdomens,
King et al.3 conclude an “increase in mean [wMel-infected]
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mosquito susceptibility to infection to a factor of 1.5” relative to
Wolbachia-negative controls. However, the value is misleading.
Replotting the Ferguson et al.5 abdomen infection rates (Fig. 2)
shows that in 23 out of 42 feedings or 54.7% (38.67–70.2%),
wMel-carrying mosquitoes displayed a lower infection pro-
portion than Wolbachia-negative controls; in 14 out of 42 or
33.3% (19.6–49.6%) the proportions were exactly equivalent;
and in only 5 out of 42 or 11.9% of feedings (3.9–25.6%) was
the proportion infected higher in wMel-carrying mosquitoes.
Thus 665 out of a total 955 or 69.6% (66.6–72.5%) of Wolba-
chia-negative mosquitoes developed abdominal infections,



























































Fig. 1 qPCR data and DENV infection rates from the original Souto-Maior et al.4 data. a Raw DENV qPCR Ct values resulting from intrathoracic
inoculations. Blue and green dots show Ct values from TET and wMel mosquitoes, respectively. Red dashed lines show Ct values from mock-injected
negative controls. b–c Proportions of TET and wMel mosquitoes classified by Souto-Maior et al.4 (and likewise by King et al.3) as qPCR positive—
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Fig. 2 Differences in abdomen infection rate [(rate in wMel)—(rate in Wolbachia-uninfected)] between wMel andWolbachia-negative mosquitoes fed
on viremic blood, replotted from the original Ferguson et al.5 data. Each dot represents a feeding on blood sourced from a different dengue-infected
patient. Negative differences (green dots) indicate a lower abdomen infection rate in wMel-carrying mosquitoes. Positive differences (blue dots) indicate a
higher abdomen infection rate in wMel-carrying mosquitoes. Black dots indicate no difference. The red line shows the mean difference across all DENV
titres. Shaded area shows data points in the 105≤ X < 106 RNA copies/ml stratum and statistical test.
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wMel-carrying mosquitoes, a 16.9% decrease in infection rate:
p= 0.0147, Fisher’s exact test.
In their susceptibility analysis, King et al.3 stratify the Ferguson
et al.5 abdomen data into groups of Log10 viral titre i.e., patients
with 105 ≤ X < 106 and 106 ≤ X < 107 RNA copies/ml etc. are
grouped independently. Using this stratification system King et al.
observe that there is an increased infection rate in the wMel
cohort in the 105 ≤ X < 106 grouping. However, while 14 out of 75
or 18.7% (10.6–29.3%) of wMel carriers were DENV positive in
abdomens compared to 9 out of 80 or 11.3% (5.3–20.3%) of
Wolbachia negatives, this difference is not statistically significant:
p= 0.372, Fisher’s exact test (Fig. 2). At all other strata the pro-
portion of infected mosquitoes was lower in the wMel cohort.
There was also no consideration of differences in output viral
titres in challenged mosquitoes in the King et al.3 model; while in
Ferguson et al.5 the 105 ≤ X < 106 stratum shows a slight increase
in infection rate for wMel, virus titre in the same mosquitoes is on
average 10–100-fold less. The need for consideration of virus in
the saliva is also paramount.
Evaluations of safety and efficacy of the Wolbachia replace-
ment approach are valuable, but must be based on robust
experimental foundations and analysis, given that misleading
‘headline’ statements can adversely impact stakeholder percep-
tions. Given low-titre asymptomatic carriers of DENV may be
important contributors to its transmission15, the study by King
et al.3 could even be interpreted as providing evidence of a risk
that Wolbachia deployment could actually increase dengue inci-
dence. Wolbachia replacement requires the release of biting
female mosquitoes, and high levels of community support are
thus essential; the intervention is particularly sensitive to any
safety concerns. The limitations in the experimental dataset on
which King et al.3 based their analysis suggest that caution is
needed when interpreting their argument for enhanced mean
DENV susceptibility in Ae. aegypti carrying wMel Wolbachia.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
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